{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:15:38Z","timestamp":1791512138121,"version":"4.3.4"},"reference-count":161,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.critrevonc.2022.103754","type":"journal-article","created":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T02:49:52Z","timestamp":1656989392000},"page":"103754","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Current knowledge of immunosuppression as a risk factor for skin cancer development"],"prefix":"10.1016","volume":"177","author":[{"given":"Mar\u00eda Paz","family":"Rollan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal","family":"Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.critrevonc.2022.103754_bib1","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1038\/ajg.2014.298","article-title":"Risk of melanoma and non-melanoma skin cancer in ulcerative colitis patients treated with Thiopurines: a nationwide retrospective cohort","volume":"109","author":"Abbas","year":"2014","journal-title":"Am. J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103754_bib2","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/jamaoncol.2015.5137","article-title":"Cancer mortality among recipients of solid-organ transplantation in Ontario, Canada","volume":"2","author":"Acuna","year":"2016","journal-title":"JAMA Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103754_bib3","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.trre.2018.07.001","article-title":"Etiology of increased cancer incidence after solid organ transplantation","volume":"32","author":"Acuna","year":"2018","journal-title":"Transplant. Rev."},{"key":"10.1016\/j.critrevonc.2022.103754_bib4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.12659\/AOT.901556","article-title":"Conversion from calcineurin Inhibitor-Based immunosuppression to mycophenolate mofetil in monotherapy reduces risk of de novo malignancies after liver transplantation","volume":"22","author":"Aguiar","year":"2017","journal-title":"Ann. Transplant."},{"issue":"12","key":"10.1016\/j.critrevonc.2022.103754_bib5","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1136\/ard.2005.036459","article-title":"Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica\/giant cell arteritis","volume":"64","author":"Askling","year":"2005","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103754_bib6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/pds.2046","article-title":"Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data","volume":"20","author":"Askling","year":"2011","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103754_bib7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10875-014-0126-0","article-title":"DOCK8 deficiency: clinical and immunological phenotype and treatment options - a review of 136 patients","volume":"35","author":"Aydin","year":"2015","journal-title":"J. Clin. Immunol."},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103754_bib8","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/art.21675","article-title":"Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis","volume":"54","author":"Baecklund","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103754_bib9","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/jgh.14041","article-title":"The risk of non-melanoma skin cancer in New Zealand in inflammatory bowel disease patients treated with thiopurines","volume":"33","author":"Bahi","year":"2018","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"9","key":"10.1016\/j.critrevonc.2022.103754_bib10","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/j.1468-3083.2011.04226.x","article-title":"Oral prednisone use and risk of keratinocyte carcinoma in non-transplant population. the VATTC trial","volume":"26","author":"Baibergenova","year":"2012","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"9","key":"10.1016\/j.critrevonc.2022.103754_bib11","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.mayocp.2018.04.025","article-title":"Immunosuppression, race, and donor-related risk factors Affect De novo Cancer Incidence Across Solid Organ Transplant Recipients","volume":"93","author":"Bhat","year":"2018","journal-title":"Mayo Clin. Proc."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103754_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/jdv.12949","article-title":"Co-existence of psoriasis and melanoma in a large urban academic centre population: A cross-sectional retrospective study","volume":"30","author":"Bhattacharya","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103754_bib13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.clim.2017.06.003","article-title":"DOCK8 deficiency: insights into pathophysiology, clinical features and management","volume":"181","author":"Biggs","year":"2017","journal-title":"Clin. Immunol."},{"issue":"12","key":"10.1016\/j.critrevonc.2022.103754_bib14","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1097\/01.TP.0000092004.83992.B2","article-title":"Mycophenolate mofetil increases adhesion capacity of tumor cells in vitro","volume":"76","author":"Blaheta","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.critrevonc.2022.103754_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2018.00117","article-title":"\u03b2-HPV infection correlates with early stages of carcinogenesis in skin tumors and patient-derived xenografts from a kidney transplant recipient cohort","volume":"9","author":"Borgogna","year":"2018","journal-title":"Front. Microbiol."},{"issue":"8","key":"10.1016\/j.critrevonc.2022.103754_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20082009","article-title":"The role of the immune system in cutaneous squamous cell carcinoma","volume":"20","author":"Bottomley","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103754_bib17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10875-017-0465-8","article-title":"The 2017 IUIS phenotypic classification for primary immunodeficiencies","volume":"38","author":"Bousfiha","year":"2018","journal-title":"J. Clin. Immunol."},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103754_bib18","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1365-2133.1993.tb11841.x","article-title":"Sunlight, keratotic skin lesions and skin cancer in renal transplant recipients","volume":"129","author":"Bouwes Bavinck","year":"1993","journal-title":"Br. J. Dermatol."},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103754_bib19","doi-asserted-by":"crossref","first-page":"JC12","DOI":"10.7326\/ACPJC-2015-162-6-012","article-title":"In ulcerative colitis, current use of thiopurines was associated with nonmelanoma skin cancer","volume":"162","author":"Bressler","year":"2015","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103754_bib20","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s40257-014-0085-5","article-title":"Optimal management of skin cancer in immunosuppressed patients","volume":"15","author":"Brin","year":"2014","journal-title":"Am. J. Clin. Dermatol."},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103754_bib21","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/art.23716","article-title":"Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate","volume":"59","author":"Buchbinder","year":"2008","journal-title":"Arthritis Care Res."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103754_bib22","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/annrheumdis-2011-201244","article-title":"Adalimumab: Long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn\u2019s disease","volume":"72","author":"Burmester","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103754_bib23","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/0190-9622(93)70201-4","article-title":"Cutaneous T-cell lymphoma associated with HIV infection","volume":"29","author":"Burns","year":"1993","journal-title":"J. Am. Acad. Dermatol."},{"issue":"9","key":"10.1016\/j.critrevonc.2022.103754_bib24","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1084\/jem.20130592","article-title":"Inherited human OX40 deficiency underlying classic kaposi sarcoma of childhood","volume":"210","author":"Byun","year":"2013","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103754_bib25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/COH.0000000000000338","article-title":"Cutaneous malignancies in HIV","volume":"12","author":"Chang","year":"2017","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103754_bib26","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s40257-019-00422-0","article-title":"HIV-related skin disease in the era of antiretroviral therapy: recognition and management","volume":"20","author":"Chelidze","year":"2019","journal-title":"Am. J. Clin. Dermatol."},{"issue":"9","key":"10.1016\/j.critrevonc.2022.103754_bib27","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/01.TP.0000100826.58738.2B","article-title":"Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation","volume":"76","author":"Cherikh","year":"2003","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103754_bib28","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jaad.2019.05.077","article-title":"Programmed cell death 1 protein and programmed death-ligand 1 inhibitors in the treatment of nonmelanoma skin cancer: a systematic review","volume":"82","author":"Choi","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103754_bib29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.tripleo.2009.08.011","article-title":"WHIM syndrome and oral squamous cell carcinoma","volume":"109","author":"Cipriani","year":"2010","journal-title":"Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endodontol."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103754_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/dju382","article-title":"Risk of Merkel cell carcinoma after solid organ transplantation","volume":"107","author":"Clarke","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103754_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2011.12.002","article-title":"Comparative incidence of cancer in HIV-AIDS patients and transplant recipients","volume":"36","author":"Cobucci","year":"2012","journal-title":"Cancer Epidemiol."},{"issue":"21","key":"10.1016\/j.critrevonc.2022.103754_bib32","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1200\/JCO.2014.59.5967","article-title":"Elevated cancer-specific mortality among HIV-infected patients in the United States","volume":"33","author":"Coghill","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103754_bib33","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/ajt.13596","article-title":"Immunosuppressive medications and squamous cell skin carcinoma: nested case-control study within the skin cancer after organ transplant (SCOT) Cohort","volume":"16","author":"Coghill","year":"2016","journal-title":"Am. J. Transpl."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103754_bib34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.det.2018.07.009","article-title":"Skin cancer and immunosuppression","volume":"37","author":"Collins","year":"2019","journal-title":"Dermatol. Clin."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103754_bib35","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/bjd.14062","article-title":"Merkel cell carcinoma in a patient with GATA2 deficiency: A novel association with primary immunodeficiency","volume":"174","author":"Crall","year":"2016","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103754_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2047-1440-3-10","article-title":"Systematic review of melanoma incidence and prognosis in solid organ transplant recipients","volume":"3","author":"Dahlke","year":"2014","journal-title":"Transplant. Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103754_bib37","article-title":"Radiotherapy and immune response: the systemic effects of a local treatment","volume":"73","author":"de","year":"2018","journal-title":"Clinics"},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103754_bib38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/TP.0000000000001447","article-title":"Cancer and mTOR inhibitors in transplant recipients","volume":"101","author":"De Fijter","year":"2017","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103754_bib39","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-med-042909-093756","article-title":"HIV infection, inflammation, immunosenescence, and aging","volume":"62","author":"Deeks","year":"2011","journal-title":"Annu. Rev. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103754_bib40","first-page":"1","article-title":"Cutaneous manifestations of primary immunodeficiency diseases in Tunisian children","volume":"10","author":"Dhouib","year":"2018","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"issue":"8","key":"10.1016\/j.critrevonc.2022.103754_bib41","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.3324\/haematol.2017.181909","article-title":"Natural history of GATA2 deficiency in a survey of 79 French and Belgian patients","volume":"103","author":"Donadieu","year":"2018","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103754_bib42","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1097\/TP.0000000000001644","article-title":"Risk of aggressive skin cancers after kidney retransplantation in patients with previous posttransplant cutaneous squamous cell carcinomas: a retrospective study of 53 cases","volume":"101","author":"Ducroux","year":"2017","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103754_bib43","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/dth.12276","article-title":"Malignant melanoma in organ transplant recipients: Incidence, outcomes, and management strategies: a review of literature","volume":"29","author":"D\u017eambov\u00e1","year":"2016","journal-title":"Dermatol. Ther."},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103754_bib44","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/0194599818808511","article-title":"Immunosuppression impact on head and neck cutaneous squamous cell carcinoma: a systematic review with meta-analysis","volume":"160","author":"Elghouche","year":"2019","journal-title":"Otolaryngol. - Head. Neck Surg."},{"issue":"17","key":"10.1016\/j.critrevonc.2022.103754_bib45","first-page":"1891","article-title":"Spectrum of cancer risk among U.S. solid organ transplant recipients: the transplant cancer match study","volume":"306","author":"Engels","year":"2011","journal-title":"JAMA Dermatol."},{"issue":"9305","key":"10.1016\/j.critrevonc.2022.103754_bib46","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(02)07668-7","article-title":"Merkel cell carcinoma and HIV infection","volume":"359","author":"Engels","year":"2002","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103754_bib47","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.transproceed.2008.11.016","article-title":"Tacrolimus versus cyclosporine for adult lung transplant recipients: a meta-analysis","volume":"41","author":"Fan","year":"2009","journal-title":"Transplant. Proc."},{"issue":"9","key":"10.1016\/j.critrevonc.2022.103754_bib48","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1097\/01.tp.0000169035.10572.c6","article-title":"Posttransplant lymphoproliferative disorder among renal transplant patients in relation to the use of mycophenolate mofetil","volume":"80","author":"Funch","year":"2005","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103754_bib49","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/QAI.0b013e318251b004","article-title":"Nonmelanoma skin cancers among HIV-infected persons in the HAART era","volume":"60","author":"Garlassi","year":"2012","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103754_bib50","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1001\/jamadermatol.2016.4920","article-title":"Incidence of and risk factors for skin cancer in organ transplant recipients in the United States","volume":"153","author":"Garrett","year":"2017","journal-title":"JAMA Dermatol."},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103754_bib51","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/j.jdcr.2015.09.017","article-title":"Merkel cell carcinoma in organ transplant recipients: Case reports and review of the literature","volume":"1","author":"Garrett","year":"2015","journal-title":"JAAD Case Rep."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103754_bib52","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.critrevonc.2004.11.011","article-title":"Skin cancer and immunosuppression","volume":"56","author":"Gerlini","year":"2005","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103754_bib53","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jaad.2016.02.1155","article-title":"Trends of skin cancer mortality after transplantation in the United States: 1987 to 2013","volume":"75","author":"Giorgia","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"issue":"14","key":"10.1016\/j.critrevonc.2022.103754_bib54","doi-asserted-by":"crossref","DOI":"10.1097\/QAD.0000000000001567","article-title":"HIV-associated Kaposi sarcoma and related diseases","volume":"31","author":"Gon\u00e7alves","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.critrevonc.2022.103754_bib55","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.aan4236","article-title":"Gut microbiome modulates response to anti\u2013PD-1 immunotherapy in melanoma patients","volume":"359","author":"Gopalakrishnan","year":"2018","journal-title":"Sciences (80-. )"},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103754_bib56","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.imlet.2007.11.012","article-title":"Immunosuppressive mechanisms in human tumors: why we still cannot cure cancer","volume":"116","author":"Gross","year":"2008","journal-title":"Immunol. Lett."},{"issue":"9581","key":"10.1016\/j.critrevonc.2022.103754_bib57","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis","volume":"370","author":"Grulich","year":"2007","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.critrevonc.2022.103754_bib58","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2165\/00003495-200767080-00006","article-title":"Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review","volume":"67","author":"Gutierrez-Dalmau","year":"2007","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103754_bib59","article-title":"Cyclosporin versus tacrolimus for liver transplanted patients","author":"Haddad","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"issue":"8","key":"10.1016\/j.critrevonc.2022.103754_bib60","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S1567-5769(03)00060-2","article-title":"Immunodeficiency and cancer: prospects for correction","volume":"3","author":"Hadden","year":"2003","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103754_bib61","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/DSS.0000000000001455","article-title":"Nonmelanoma skin cancer risk in patients with inflammatory bowel disease undergoing thiopurine therapy: a systematic review of the literature","volume":"44","author":"Hagen","year":"2018","journal-title":"Dermatol. Surg."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103754_bib62","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaci.2017.06.009","article-title":"Intrinsic and extrinsic causes of malignancies in patients with primary immunodeficiency disorders","volume":"141","author":"Hauck","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103754_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2005.01.010","article-title":"Adverse effects of topical glucocorticosteroids","volume":"54","author":"Hengge","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"issue":"11","key":"10.1016\/j.critrevonc.2022.103754_bib64","doi-asserted-by":"crossref","first-page":"e647","DOI":"10.1016\/S2352-3018(18)30179-6","article-title":"Incidence of first and second primary cancers diagnosed among people with HIV, 1985\u20132013: a population-based, registry linkage study","volume":"5","author":"Hessol","year":"2018","journal-title":"Lancet HIV"},{"issue":"11","key":"10.1016\/j.critrevonc.2022.103754_bib65","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1001\/archderm.1980.01640350070019","article-title":"Kaposi\u2019s Sarcoma after immunosuppressive therapy with prednisone","volume":"116","author":"Hoshaw","year":"1980","journal-title":"Arch. Dermatol."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103754_bib66","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s40257-018-0355-8","article-title":"Skin cancer following solid organ transplantation: a review of risk factors and models of care","volume":"19","author":"Howard","year":"2018","journal-title":"Am. J. Clin. Dermatol."},{"issue":"11","key":"10.1016\/j.critrevonc.2022.103754_bib67","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.2217\/fon.15.70","article-title":"Clinical efficacy of mTOR inhibitors in solid tumors: a systematic review","volume":"11","author":"Huang","year":"2015","journal-title":"Futur. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103754_bib68","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/pbc.25779","article-title":"Kaposi sarcoma of childhood: inborn or acquired immunodeficiency to oncogenic HHV-8","volume":"63","author":"Jackson","year":"2016","journal-title":"Pediatr. Blood Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103754_bib69","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/sj.bjc.6604796","article-title":"Use of oral glucocorticoids and risk of skin cancer and non-Hodgkin\u2019s lymphoma: a population-based case-control study","volume":"100","author":"Jensen","year":"2009","journal-title":"Br. J. Cancer"},{"issue":"1\u20132","key":"10.1016\/j.critrevonc.2022.103754_bib70","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0041-1345(98)01928-9","article-title":"Are renal transplant recipients on CsA-based immunosuppressive regimens more likely to develop skin cancer than those on azathioprine and prednisolone?","volume":"31","author":"Jensen","year":"1999","journal-title":"Transplant. Proc."},{"issue":"12","key":"10.1016\/j.critrevonc.2022.103754_bib71","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1111\/ajt.13863","article-title":"Azathioprine and risk of skin cancer in organ transplant recipients: systematic review and meta-analysis","volume":"16","author":"Jiyad","year":"2016","journal-title":"Am. J. Transplant."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103754_bib72","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clim.2014.10.003","article-title":"Primary immunodeficiencies in the Netherlands: national patient data demonstrate the increased risk of malignancy","volume":"156","author":"Jonkman-Berk","year":"2015","journal-title":"Clin. Immunol."},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103754_bib73","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1054\/bjoc.2001.1931","article-title":"Non-melanoma skin cancers and glucocorticoid therapy","volume":"85","author":"Karagas","year":"2001","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.critrevonc.2022.103754_bib74","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/archderm.1995.01690230059010","article-title":"Cutaneous presentations of lymphoma in human immunodeficiency virus disease","volume":"131","author":"Kerschmann","year":"1995","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.critrevonc.2022.103754_bib75","first-page":"1","article-title":"Mortality associated with development of squamous cell cancer in patients with inflammatory bowel disease receiving treatment With Thiopurines","author":"Khan","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103754_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pbc.28091","article-title":"Malignancy and lymphoid proliferation in primary immune deficiencies; hard to define, hard to treat","volume":"67","author":"Kiykim","year":"2020","journal-title":"Pediatr. Blood Cancer"},{"issue":"g6679","key":"10.1016\/j.critrevonc.2022.103754_bib77","first-page":"1","article-title":"Effect of sirolimus on malignancy and survival after kidney transplantation: Systematic review and meta-analysis of individual patient data","volume":"349","author":"Knoll","year":"2014","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103754_bib78","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.cll.2017.06.001","article-title":"The immunology of melanoma","volume":"37","author":"Ko","year":"2017","journal-title":"Clin. Lab. Med."},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103754_bib79","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cgh.2014.05.015","article-title":"Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis","volume":"13","author":"Kotlyar","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103754_bib80","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.trre.2009.02.004","article-title":"Skin cancer after transplantation","volume":"23","author":"Kovach","year":"2009","journal-title":"Transplant. Rev."},{"issue":"12","key":"10.1016\/j.critrevonc.2022.103754_bib81","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1111\/j.1600-6143.2005.01117.x","article-title":"Addition of MMF to dual immunosuppression does not increase the risk of malignant short-term death after liver transplantation","volume":"5","author":"Lake","year":"2005","journal-title":"Am. J. Transpl."},{"issue":"14","key":"10.1016\/j.critrevonc.2022.103754_bib82","article-title":"Targeting tumor-associated macrophages in head and neck squamous cell carcinoma","volume":"106","author":"Li","year":"2020","journal-title":"Oral Oncol."},{"key":"10.1016\/j.critrevonc.2022.103754_bib83","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0065-230X(08)60815-5","article-title":"The oportunistic tumors of immune deficiency","volume":"54","author":"Loachim","year":"1990","journal-title":"Adv. Cancer Res."},{"issue":"11","key":"10.1016\/j.critrevonc.2022.103754_bib84","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/jnci\/djq134","article-title":"Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion","volume":"102","author":"Lodi","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.critrevonc.2022.103754_bib85","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.critrevonc.2004.12.012","article-title":"Post-transplant cutaneous T-cell lymphomas","volume":"56","author":"Lok","year":"2005","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"7","key":"10.1016\/j.critrevonc.2022.103754_bib86","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/15384047.2017.1323596","article-title":"Immune surveillance in melanoma: From immune attack to melanoma escape and even counterattack","volume":"18","author":"Mahmoud","year":"2017","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.critrevonc.2022.103754_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/423401","article-title":"A review of the potential utility of mycophenolate mofetil as a cancer therapeutic","author":"Majd","year":"2014","journal-title":"J. Cancer Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103754_bib88","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0022-3476(99)70456-7","article-title":"Increased incidence of cancer in patients with cartilage-hair hypoplasia","volume":"134","author":"M\u00e4kitie","year":"1999","journal-title":"J. Pediatr."},{"issue":"11","key":"10.1016\/j.critrevonc.2022.103754_bib89","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1136\/ard.2010.149419","article-title":"Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: A systematic review and meta-analysis","volume":"70","author":"Mariette","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103754_bib90","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.jaci.2017.05.024","article-title":"Cancer in primary immunodeficiency diseases: cancer incidence in the United States Immune Deficiency Network Registry","volume":"141","author":"Mayor","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"issue":"10","key":"10.1016\/j.critrevonc.2022.103754_bib91","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1111\/ajt.14382","article-title":"Skin cancers in organ transplant recipients","volume":"17","author":"Mittal","year":"2017","journal-title":"Am. J. Transplant."},{"issue":"12","key":"10.1016\/j.critrevonc.2022.103754_bib92","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1002\/cncr.20309","article-title":"The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: the EuroSIDA study","volume":"100","author":"Mocroft","year":"2004","journal-title":"Cancer"},{"issue":"365","key":"10.1016\/j.critrevonc.2022.103754_bib93","first-page":"1","article-title":"Cancers related to immunodeficiencies: update and perspectives","volume":"7","author":"Mortaz","year":"2016","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103754_bib94","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3109\/09546634.2011.590792","article-title":"Cyclosporine and skin cancer: An international dermatologic perspective over 25 years of experience. A comprehensive review and pursuit to define safe use of cyclosporine in dermatology","volume":"23","author":"Muellenhoff","year":"2012","journal-title":"J. Dermatol. Treat."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103754_bib95","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/000155599750011426","article-title":"Cutaneous T-cell lymphoma and human immunodeficiency virus infection: 2 cases and a review of the literature","volume":"79","author":"Mun\u00f5z-P\u00e9rez","year":"1999","journal-title":"Acta Derm. Venereol."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103754_bib96","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/ajd.12072","article-title":"Accrual of non-melanoma skin cancer in renal-transplant recipients: Experience of a Victorian tertiary referral institution","volume":"55","author":"Ng","year":"2014","journal-title":"Australas. J. Dermatol."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103754_bib97","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/pcmr.12671","article-title":"Melanoma in patients with GATA2 deficiency","volume":"31","author":"Nguyen","year":"2018","journal-title":"Pigment Cell Melanoma Res."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103754_bib98","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jaad.2010.11.062","article-title":"Skin cancer in solid organ transplant recipients: advances in therapy and management: Part II. Management of skin cancer in solid organ transplant recipients","volume":"65","author":"O\u2019Reilly Zwald","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103754_bib99","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jaad.2018.03.024","article-title":"Risk of skin cancer in patients with HIV: a Danish nationwide cohort study","volume":"79","author":"Omland","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103754_bib100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0190-9622(99)70525-6","article-title":"Skin cancer in Australian heart transplant recipients.","volume":"40","author":"Ong","year":"1999","journal-title":"J. Am. Acad. Dermatol."},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103754_bib101","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cellimm.2015.09.011","article-title":"Tolerance and immune suppression in the tumor microenvironment","volume":"299","author":"Ostrand-Rosenberg","year":"2016","journal-title":"Cell. Immunol."},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103754_bib102","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.jaad.2007.05.021","article-title":"Sirolimus (rapamycin): From the soil of Easter Island to a bright future","volume":"57","author":"Paghdal","year":"2007","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103754_bib103","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/QAD.0000000000000922","article-title":"Prevalence of non-HIV cancer risk factors in persons living with HIV\/AIDS: a meta-analysis","volume":"30","author":"Parka","year":"2016","journal-title":"AIDS"},{"issue":"10","key":"10.1016\/j.critrevonc.2022.103754_bib104","doi-asserted-by":"crossref","first-page":"728","DOI":"10.7326\/0003-4819-148-10-200805200-00005","article-title":"Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003","volume":"148","author":"Patel","year":"2008","journal-title":"Ann. Intern. Med."},{"issue":"3\u20134","key":"10.1016\/j.critrevonc.2022.103754_bib105","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1155\/2010\/345436","article-title":"Epidermodysplasia verruciformis and susceptibility to HPV","volume":"29","author":"Patel","year":"2010","journal-title":"Dis. Markers"},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103754_bib106","article-title":"Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients","volume":"vol.","author":"Penninga","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103754_bib107","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1053\/j.gastro.2011.06.050","article-title":"Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease","volume":"141","author":"Peyrin-Biroulet","year":"2011","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.critrevonc.2022.103754_bib108","first-page":"33","article-title":"Cutaneous squamous cell carcinoma ( cSCC) and immunosurveillance \u2013 the impact of immunosuppression on frequency of cSCC","volume":"33","author":"Plasmeijer","year":"2019","journal-title":"JEADV"},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103754_bib109","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1111\/bjd.15170","article-title":"Methotrexate treatment and risk for cutaneous malignant melanoma: a retrospective comparative registry-based cohort study","volume":"176","author":"Polesie","year":"2017","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103754_bib110","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jaad.2017.02.032","article-title":"Methotrexate treatment in patients with a history of cutaneous melanoma and the risk of a consecutive primary melanoma: a national retrospective registry-based cohort study","volume":"77","author":"Polesie","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"issue":"9","key":"10.1016\/j.critrevonc.2022.103754_bib111","doi-asserted-by":"crossref","first-page":"888","DOI":"10.2340\/00015555-2987","article-title":"Methotrexate exposure and risk of cutaneous malignant melanoma: No evidence of a dose-response relationship","volume":"98","author":"Polesie","year":"2018","journal-title":"Acta Derm. Venereol."},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103754_bib112","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/ssu.2980050607","article-title":"Cancer- induced immunosuppression: implications for therapy\u00a0?","volume":"5","author":"Pollock","year":"1989","journal-title":"Semin Surg. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103754_bib113","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.iac.2015.07.001","article-title":"Overview of immunodeficiency disorders","volume":"35","author":"Raje","year":"2015","journal-title":"Immunol. Allergy Clin. N. Am."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103754_bib114","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jaad.2005.10.015","article-title":"Primary cutaneous T-cell lymphoma occurring after organ transplantation","volume":"54","author":"Ravat","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"issue":"7","key":"10.1016\/j.critrevonc.2022.103754_bib115","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","article-title":"Morbidity and mortality in common variable immune deficiency over 4 decades","volume":"119","author":"Resnick","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103754_bib116","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-008-9069-8","article-title":"Spontaneous remission of \u2018methotrexate-associated lymphoproliferative disorders\u2019 after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature","volume":"26","author":"Rizzi","year":"2009","journal-title":"Med. Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2022.103754_bib117","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1038\/jid.2015.312","article-title":"Melanoma risk and survival among organ transplant recipients","volume":"135","author":"Robbins","year":"2015","journal-title":"J. Invest. Dermatol."},{"issue":"12","key":"10.1016\/j.critrevonc.2022.103754_bib118","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1111\/j.1600-6143.2005.01125.x","article-title":"Prospective registry-based observational cohort study of the long-term risk of malignancies in renal transplant patients treated with mycophenolate mofetil","volume":"5","author":"Robson","year":"2005","journal-title":"Am. J. Transpl."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103754_bib119","first-page":"20","article-title":"[Patients with solid organ transplantation and skin cancer: determination of risk factors with emphasis in photoexposure and immunosuppressive regimen. Experience in a third level hospital]","volume":"151","author":"Rodr\u00edguez-Acosta","year":"2015","journal-title":"Gac. Med. Mex."},{"issue":"2 B","key":"10.1016\/j.critrevonc.2022.103754_bib120","first-page":"1263","article-title":"Development of cancer in patients with primary immunodeficiencies","volume":"28","author":"Salavoura","year":"2008","journal-title":"Anticancer Res."},{"issue":"7","key":"10.1016\/j.critrevonc.2022.103754_bib121","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/jdv.13266","article-title":"Neoadjuvant intralesional methotrexate in cutaneous squamous cell carcinoma: a comparative cohort study","volume":"30","author":"Salido-Vallejo","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"10","key":"10.1016\/j.critrevonc.2022.103754_bib122","first-page":"1","article-title":"Immunotherapy \u2013 strategies for expanding its role in the treatment of all major tumor sites","volume":"11","author":"Sanghera","year":"2019","journal-title":"Cureus"},{"issue":"1149","key":"10.1016\/j.critrevonc.2022.103754_bib123","first-page":"1","article-title":"A tumor profile in primary immune deficiencies challenges the cancer immune surveillance concept","volume":"9","author":"Satg\u00e9","year":"2018","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103754_bib124","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2340\/00015555-3123","article-title":"Skin cancer associated genodermatoses: a literature review","volume":"99","author":"Schierbeck","year":"2019","journal-title":"Acta Derm. Venereol."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103754_bib125","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jaad.2008.05.001","article-title":"Kaposi sarcoma: a continuing conundrum","volume":"59","author":"Schwartz","year":"2008","journal-title":"J. Am. Acad. Dermatol."},{"issue":"8","key":"10.1016\/j.critrevonc.2022.103754_bib126","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1111\/ajt.12281","article-title":"Primary cutaneous posttransplant lymphoproliferative disorders in solid organ transplant recipients: A multicenter European case series","volume":"13","author":"Se\u00e7kin","year":"2013","journal-title":"Am. J. Transpl."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103754_bib127","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jdermsci.2016.04.013","article-title":"Cutaneous squamous cell carcinomas with markers of increased metastatic risk are associated with elevated numbers of neutrophils and\/or granulocytic myeloid derived suppressor cells","volume":"83","author":"Seddon","year":"2016","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.critrevonc.2022.103754_bib128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2018.00086","article-title":"Anti-PD-1 and anti-CTLA-4 therapies in cancer: Mechanisms of action, efficacy, and limitations","volume":"8","author":"Seidel","year":"2018","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103754_bib129","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.rdc.2016.09.006","article-title":"Malignancy and the risks of biologic therapies: current status","volume":"43","author":"Seror","year":"2017","journal-title":"Rheum. Dis. Clin. N. Am."},{"issue":"14","key":"10.1016\/j.critrevonc.2022.103754_bib130","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.ejca.2007.07.015","article-title":"Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe","volume":"43","author":"Serraino","year":"2007","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103754_bib131","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1440-1746.2011.06865.x","article-title":"Use of thiopurines in the treatment of inflammatory bowel disease is associated with an increased risk of non-melanoma skin cancer in an at-risk population: a cohort study","volume":"27","author":"Setshedi","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103754_bib132","first-page":"1","article-title":"Melanoma cell-derived exosomes in plasma of melanoma patients suppress functions of immune effector cells","volume":"10","author":"Sharma","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103754_bib133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-018-0620-1","article-title":"Tumor-associated macrophages derived CCL18 promotes metastasis in squamous cell carcinoma of the head and neck","volume":"18","author":"She","year":"2018","journal-title":"Cancer Cell Int."},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103754_bib134","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/01.TP.0000436907.56425.5c","article-title":"Predictors of cancer risk in the long-term solid-organ transplant recipient","volume":"97","author":"Sherston","year":"2014","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.critrevonc.2022.103754_bib135","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/jnci\/djr076","article-title":"Cancer burden in the HIV-infected population in the United States","volume":"103","author":"Shiels","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"issue":"7","key":"10.1016\/j.critrevonc.2022.103754_bib136","doi-asserted-by":"crossref","first-page":"507","DOI":"10.7326\/M14-2768","article-title":"Cumulative incidence of cancer among persons with HIV in North America: A cohort study","volume":"163","author":"Silverberg","year":"2015","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103754_bib137","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/jnci\/djs529","article-title":"HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer","volume":"105","author":"Silverberg","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103754_bib138","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.semarthrit.2013.08.003","article-title":"Comparative cancer risk associated with methotrexate, other non-biologic and biologic disease-modifying anti-rheumatic drugs","volume":"43","author":"Solomon","year":"2014","journal-title":"Semin. Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103754_bib139","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamadermatol.2016.0192","article-title":"Nonmelanoma skin cancer with aggressive subclinical extension in immunosuppressed patients","volume":"152","author":"Song","year":"2016","journal-title":"JAMA Dermatol."},{"issue":"9","key":"10.1016\/j.critrevonc.2022.103754_bib140","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/jnci\/djh118","article-title":"Skin cancers and non-Hodgkin lymphoma among users of systemic Glucocorticoids: a population-based cohort study","volume":"96","author":"S\u00f8rensen","year":"2004","journal-title":"J. Natl. Cancer Inst."},{"issue":"13","key":"10.1016\/j.critrevonc.2022.103754_bib141","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa042831","article-title":"Sirolimus for Kaposi\u2019s sarcoma in renal-transplant recipients","volume":"352","author":"Stallone","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103754_bib142","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1034\/j.1600-0781.2002.00765.x","article-title":"Cyclosporin-A suppresses p53-dependent repair DNA synthesis and apoptosis following ultraviolet-B irradiation","volume":"18","author":"Sugie","year":"2002","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103754_bib143","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.aller.2017.01.006","article-title":"Epidemiology and pathophysiology of malignancy in common variable immunodeficiency?","volume":"45","author":"Tak Manesh","year":"2017","journal-title":"Allergol. Immunopathol."},{"issue":"8","key":"10.1016\/j.critrevonc.2022.103754_bib144","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.annepidem.2014.05.009","article-title":"Systemic glucocorticoid use and early-onset basal cell carcinoma","volume":"24","author":"Troche","year":"2015","journal-title":"Ann. Epidemiol."},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103754_bib145","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/j.1365-2133.2011.10322.x","article-title":"Viral oncogenesis and its role in nonmelanoma skin cancer","volume":"164","author":"Tuttleton Arron","year":"2011","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103754_bib146","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.semcancer.2012.02.003","article-title":"Melanoma-induced immunosuppression and its neutralization","volume":"22","author":"Umansky","year":"2012","journal-title":"Semin. Cancer Biol."},{"issue":"8","key":"10.1016\/j.critrevonc.2022.103754_bib147","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1182\/blood-2010-03-272351","article-title":"Are antibody deficiency disorders associated with a narrower range of cancers than other forms of immunodeficiency?","volume":"116","author":"Vajdic","year":"2010","journal-title":"Blood"},{"issue":"6264","key":"10.1016\/j.critrevonc.2022.103754_bib148","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.aad1329","article-title":"Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota","volume":"350","author":"V\u00e9tizou","year":"2015","journal-title":"Sciences (80-. )."},{"key":"10.1016\/j.critrevonc.2022.103754_bib149","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0300-483X(02)00612-1","article-title":"Immunosuppressive drugs and cancer","volume":"185","author":"Vial","year":"2003","journal-title":"Toxicology"},{"key":"10.1016\/j.critrevonc.2022.103754_bib150","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1016\/j.semcancer.2015.03.004","article-title":"Immune evasion in cancer: mechanistic basis and therapeutic strategies","volume":"35","author":"Vinay","year":"2015","journal-title":"Semin. Cancer Biol."},{"issue":"10","key":"10.1016\/j.critrevonc.2022.103754_bib151","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/carcin\/bgv123","article-title":"Immunosuppression associated with chronic inflammation in the tumor microenvironment","volume":"36","author":"Wang","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.critrevonc.2022.103754_bib152","first-page":"1","article-title":"Targeting the immune microenvironment in the treatment of head and neck squamous cell carcinoma","volume":"9","author":"Wang","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103754_bib153","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ejmech.2018.09.027","article-title":"Side effects of methotrexate therapy for rheumatoid arthritis: a systematic review","volume":"158","author":"Wang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103754_bib154","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1067\/mjd.2001.112224","article-title":"Posttransplant primary cutaneous T-cell lymphoma","volume":"44","author":"Ward","year":"2001","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.critrevonc.2022.103754_bib155","first-page":"2","article-title":"Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients (Review)","volume":"no. 4","author":"Webster","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103754_bib156","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.seminhematol.2017.05.002","article-title":"GATA2 deficiency and related myeloid neoplasms","volume":"54","author":"Wlodarski","year":"2017","journal-title":"Semin. Hematol."},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103754_bib157","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/QAI.0000000000001719","article-title":"Brief report: cutaneous melanoma risk among people with HIV in the United States and Canada","volume":"78","author":"Yanik","year":"2018","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"9","key":"10.1016\/j.critrevonc.2022.103754_bib158","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/cam4.487","article-title":"Sirolimus effects on cancer incidence after kidney transplantation: A meta-analysis","volume":"4","author":"Yanik","year":"2015","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103754_bib159","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.healun.2008.10.004","article-title":"Tacrolimus versus cyclosporine microemulsion for heart transplant recipients: a meta-analysis","volume":"28","author":"Ye","year":"2009","journal-title":"J. Hear. Lung Transplant."},{"issue":"7","key":"10.1016\/j.critrevonc.2022.103754_bib160","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1177\/0956462415586316","article-title":"The risk of non-melanoma skin cancer in HIV-infected patients: new data and meta-analysis","volume":"27","author":"Zhao","year":"2016","journal-title":"Int. J. STD AIDS"},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103754_bib161","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/QAI.0000000000001033","article-title":"Non-AIDS-defining cancer mortality: Emerging patterns in the late HAART era","volume":"73","author":"Zucchetto","year":"2016","journal-title":"J. Acquir. Immune Defic. Syndr."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842822001780?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842822001780?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:42:43Z","timestamp":1760902963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842822001780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":161,"alternative-id":["S1040842822001780"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103754","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current knowledge of immunosuppression as a risk factor for skin cancer development","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103754","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103754"}}